Standardized surveillance enabled early tumor detection for a variety of cancer predisposition syndromes, allowing for surgical resection and treatment of children and young adults with cancer, study findings in JAMA Oncology showed.
The results, when analyzed across all imaging modalities, also generated few false-positive and false-negative findings, according to researchers.
“The increasing integration of germline genetic testing into routine treatment of children with cancer is leading to the recognition of more children with an underlying [cancer predisposition syndrome],”